Related Experiment Videos
Etoposide differentially affects bone marrow and dermal derived endothelial cells.
S W Adams1, Lin Wang, J Fortney
1Department of Pediatrics, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, West Virginia University, Morgantown, WV 26505, USA. swadams@hsc.wvu.edu
Journal of Cellular and Molecular Medicine
|October 20, 2004
Summary
Marrow endothelial cells are more sensitive to chemotherapy than dermal cells, showing reduced viability and altered protein expression. This highlights differences in cellular response to chemotherapy, impacting hematopoietic recovery models.
Area of Science:
- Hematology
- Cell Biology
- Oncology
Background:
- Chemotherapy can alter the bone marrow microenvironment, potentially affecting hematopoietic recovery after transplantation.
- In vitro models are crucial for understanding how specific chemotherapy drugs impact the bone marrow microenvironment.
Purpose of the Study:
- To investigate differential responses of dermal (HMEC-1) and bone marrow-derived endothelial cells (BMEC-1) to chemotherapy exposure.
- To identify specific protein expression changes in endothelial cells following chemotherapy treatment.
Main Methods:
- Exposure of HMEC-1 and BMEC-1 cell lines to etoposide chemotherapy.
- Assessment of cell viability using quantitative measures.
- Analysis of protein expression levels for focal adhesion kinase (FAK), VCAM-1, and VE-Cadherin via Western blotting or similar techniques.
Main Results:
- BMEC-1 cells exhibited significantly lower viability compared to HMEC-1 cells after etoposide exposure.
- Chemotherapy treatment led to reduced FAK and VCAM-1 protein expression in BMEC-1 cells, but not significantly in HMEC-1 cells.
- Baseline VE-Cadherin protein levels differed between the two cell lines, with only modest alterations post-treatment.
Conclusions:
- Bone marrow-derived endothelial cells demonstrate distinct protein disruptions following chemotherapy compared to dermal endothelial cells.
- These chemotherapy-induced changes in BMEC-1 may affect their role in regulating hematopoietic cell trafficking within the bone marrow.
- The differential sensitivity and protein response underscore the importance of using specific endothelial cell models when studying chemotherapy effects on the bone marrow microenvironment.